Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Patent Awarded for COPD Dry Powder Inhaler Formula

A formulation for dry powder inhalers to treat respiratory diseases that its developers say delivers medication to the lungs more efficiently received a U.S. patent. . . . → Read More: Patent Awarded for COPD Dry Powder Inhaler Formula

Univ. Spin-Off Creating Baby Brain Development Food

A start-up enterprise spun-off from the Duke-NUS medical school in Singapore is licensing research for a new food product for mothers to help a baby’s cognitive development. . . . → Read More: Univ. Spin-Off Creating Baby Brain Development Food

$2 Billion Biotech Licensing Deal Cancelled

A licensing deal with a potential value of more than $2 billion between two biotechnology companies for a new breast cancer drug was cancelled on Friday. . . . → Read More: $2 Billion Biotech Licensing Deal Cancelled

Shire Licensing Dry Eye Disease Treatment in $535M Deal

An experimental drug for treating dry eye disease, a common disorder affecting older individuals, is being licensed by international pharmaceutical company Shire plc. . . . → Read More: Shire Licensing Dry Eye Disease Treatment in $535M Deal

Start-Up Licensing Flexible Genome-Editing Technology

A start-up biotechnology company is licensing techniques from two universities that make genome editing more flexible and better control gene expression. . . . → Read More: Start-Up Licensing Flexible Genome-Editing Technology

NIH Funds Seen Boosting Industry Patents

An analysis of grants issued by National Institutes of Health shows a large percentage of those grants, directly or indirectly, result in patented technologies in industry. . . . → Read More: NIH Funds Seen Boosting Industry Patents

Univ. of California to Gain European Crispr-Cas9 Patent

A patent dispute among top research universities took another turn, as the European Patent Office announced its intention to grant a patent to University of California for its genome editing techniques. . . . → Read More: Univ. of California to Gain European Crispr-Cas9 Patent

Univ. Spin-Off Developing Non-Toxic Bedbug Killer

Research from a lab at Pennsylvania State University led to a technology for controlling bedbug infestations with natural enemies that are harmless to humans. . . . → Read More: Univ. Spin-Off Developing Non-Toxic Bedbug Killer

Allergan to Option Gene Editing for Eye Diseases

International drug maker Allergan is gaining access to treatments for inherited eye diseases being developed by Editas Medicine, a spin-off enterprise from MIT and Harvard. . . . → Read More: Allergan to Option Gene Editing for Eye Diseases

Process Converts Food Waste to Auto Tire Materials

Agricultural scientists in Ohio are developing a process for converting common food waste into materials used in car tires, and filed a patent for these techniques. . . . → Read More: Process Converts Food Waste to Auto Tire Materials